drugset / Trial / NCT04586504

Dose-Finding Study of Intranasal Midazolam for Procedural Sedation in Children

NCT04586504

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Dose-finding study to compare intranasal midazolam doses of 0.2, 0.3, 0.4 and 0.5 mg/kg in children undergoing laceration repair to achieve the following aims: Specific Aim #1: To determine the most effective dose of intranasal midazolam for producing adequate sedation state associated with each dose. Specific Aim #2: To determine the time to recovery and describe the adverse events associated with each dose.

Timeline

Start
2021-09-08
Primary completion
2024-05-14
Completion
2024-05-14

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule 0.2 mg/kg Intranasal
Subject Midazolam Small molecule 0.3 mg/kg Intranasal
Subject Midazolam Small molecule 0.4 mg/kg Intranasal
Subject Midazolam Small molecule 0.5 mg/kg Intranasal

Indications